Leaderboards/acute lymphoblastic leukemia research

acute lymphoblastic leukemia research

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Ti‐Cheng Chang
St. Jude Children's Research Hospital
99
2
Jun J. Yang
St. Jude Children's Research Hospital
80
3
Satoshi Yoshimura
St. Jude Children's Research Hospital
70
4
Stephan A. Grupp
Children's Hospital of Philadelphia
60

Rising Stars Papers

1
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
Cancer Cell|2024
31 cit.
2
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia
Clinical Cancer Research|2026
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Robert Chiesa
Great Ormond Street Hospital
99
2
Nicola Gökbuget
Goethe University Frankfurt
90
3
Monika Dangore
Institute of Engineering
70
4
Sarvin Mohammadi‐Aghdam
Payame Noor University
50
5
Janardan Pawar
Department of Commerce
50
6
Umair Saeed
Sindh Madressatul Islam University
40
7
Yogesh Kisan Mali
Raisoni Group of Institutions
40
8
Rathana Kim
Centre National de la Recherche Scientifique
30
9
Rayne H. Rouce
Baylor College of Medicine
30
10
Jayadev Mavuluri
St. Jude Children's Research Hospital
20

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Gordon W. Dewald
Mayo Clinic
99
2
Mignon L. Loh
Seattle Children's Hospital
90
3
Vahid Asnafi
Hôpital Necker-Enfants Malades
90
4
Gregory H. Reaman
Cincinnati Children's Hospital Medical Center
80
5
Elizabeth A. Raetz
NYU Langone Health
80
6
William E. Evans
St. Jude Children's Research Hospital
70
7
Nirali N. Shah
National Institutes of Health
60
8
Michel Sadelain
Cornell University
60
9
Hervé Dombret
Hôpital Saint-Jacques
50
10
Richard S. Ungerleider
Theradex Oncology (United States)
40

All-Time Leaders Papers

1
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Cancer Discovery|2021
551 cit.
2
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape
Molecular Therapy|2018
256 cit.
3
CAR therapy: the CD19 paradigm
Journal of Clinical Investigation|2015
228 cit.
4
TET2 guards against unchecked BATF3-induced CAR T cell expansion
Nature|2023
142 cit.
5
Disruption of <i>SUV39H1</i> -Mediated H3K9 Methylation Sustains CAR T-cell Function
Cancer Discovery|2023
77 cit.
6
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup
Science Translational Medicine|2021
41 cit.
7
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL
Blood|2021
36 cit.
8
Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion and altered sensory function in mice
Scientific Reports|2016
6 cit.
9
A metabolic synthetic lethality of PI3K-driven cancer
Research Square|2024
0 cit.

Reagents for acute lymphoblastic leukemia research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Bio-Rad

2-Mercaptoethanol (BME)

#1610710
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

TECPR1 (D6C10) Rabbit Monoclonal Antibody

Cited in 5 papers
#8097$161
View Evidence →Cell Signaling Technology

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 5 papers
#94805$465
View Evidence →Cell Signaling Technology

Phospho-Jak2 (Tyr221) Antibody

Cited in 5 papers
#3774$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Phospho-Tyrosine Mouse Monoclonal Antibody (P-Tyr-100) (Alexa Fluor® 488 Conjugate)

Cited in 8 papers
#9414$493
View Evidence →Cell Signaling Technology

Phospho-Zap-70 (Tyr319)/Syk (Tyr352) (65E4) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 532 Conjugate)

Cited in 6 papers
#80986$486
View Evidence →Cell Signaling Technology

ASK1 Antibody

Cited in 6 papers
#3762$317
View Evidence →